Supplement researchSourced from PubMed and NIH
NutriStack
Free iPhone appUpdated September 28, 2026

Supplement × Prescription·Evidence index

Vitamin K1 and Warfarin: what the research found

PubMed indexes 8 records that name Vitamin K1 and Warfarin together, either in the title or in an interaction, co-administration, or pharmacokinetic context. The key findings come first, in the authors’ own words, followed by every study with its design and PubMed link.

A summary of published research, not medical advice. A pharmacist can check any combination against your full list of medicines and supplements.

Key findings

What the studies concluded.

Reviews and human studies first. Each quote is the authors’ own conclusion about their study, not a NutriStack assessment, and a single study is not a consensus.

“Restriction of dietary vitamin K intake does not seem to be a valid strategy to improve anticoagulation quality with VKAs. It would be, perhaps, more relevant to maintain stable dietary habit, avoiding wide changes in the intake of vitamin K.”

Violi et al. · 2016 · Review or meta-analysis · details

“In patients receiving warfarin therapy who have an increased INR and are at risk of bleeding, oral vitamin K1 therapy may be safer, less painful, and more cost-effective than the traditional parenteral route of administration.”

Harrell et al. · 1995 · Human study · details

“Following the administration of vitamin K1, the maximum plasma concentration and area under the plasma concentration time curve values for the metabolite vitamin K1 2,3-epoxide were greater after S warfarin than after R warfarin. The greater anticoagulant potency of S warfarin is reflected by a greater degree of inhibition of vitamin K1 epoxide reductase.”

The research

8 studies naming Vitamin K1 and Warfarin.

Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.

Oral vitamin K1: an option to reduce warfarin's activity.

The Annals of pharmacotherapy · 1995 · PMID 8672826

Case ReportsReviewHuman subjects

“In patients receiving warfarin therapy who have an increased INR and are at risk of bleeding, oral vitamin K1 therapy may be safer, less painful, and more cost-effective than the traditional parenteral route of administration.”

Harrell et al. · Authors' conclusion

Names both Vitamin K1 and Warfarin in its title.

Enantiomers of warfarin and vitamin K1 metabolism.

British journal of clinical pharmacology · 1986 · PMID 3567019

Human subjects

“Following the administration of vitamin K1, the maximum plasma concentration and area under the plasma concentration time curve values for the metabolite vitamin K1 2,3-epoxide were greater after S warfarin than after R warfarin. The greater anticoagulant potency of S warfarin is reflected by a greater degree of inhibition of vitamin K1 epoxide reductase.”

Choonara et al. · From the abstract

Names both Vitamin K1 and Warfarin in its title.

Antidotal effect of vitamin K1 against warfarin-induced anticoagulation in horses.

American journal of veterinary research · 1986 · PMID 3777660

Animal study

“The therapeutic response time, without supportive therapy, after discontinuation of warfarin administration was 30 hours, and there was a PT reversal time of approximately 5 days from the last dose of warfarin. The 100-mg dose of vitamin K1 shortened the therapeutic response time to 12 hours and the PT reversal time to 24 hours.(ABSTRACT TRUNCATED AT 250 WORDS)”

Byars et al. · From the abstract

Names both Vitamin K1 and Warfarin in its title.

Anti-inflammatory effect of warfarin and vitamin K1.

Naunyn-Schmiedeberg's archives of pharmacology · 1979 · PMID 573373

Animal study

“5. The anti-inflammatory effect of both sodium warfarin and of vitamin K1 in rats, is not interfered with by previous adrenalectomy.”

Eichbaum et al. · From the abstract

Names both Vitamin K1 and Warfarin in its title.

Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True?: A Systematic Review.

Medicine · 2016 · PMID 26962786

Systematic ReviewHuman subjects

“Restriction of dietary vitamin K intake does not seem to be a valid strategy to improve anticoagulation quality with VKAs. It would be, perhaps, more relevant to maintain stable dietary habit, avoiding wide changes in the intake of vitamin K.”

Violi et al. · From the abstract

Names Vitamin K1 and Warfarin together in an interaction, co-administration, or pharmacokinetic context.

Persistent Coagulopathy After Synthetic Cannabinoid Use.

Cureus · 2023 · PMID 37065401

Case Reports

“In contrast to warfarin, BDF has an extremely long-acting biological half-life of 90 days due to minimal metabolism and limited clearance. Here, we report a 45-year-old male who presented to the emergency room with a 12-day history of gross hematuria and mucosal bleeding without previous history of coagulopathy and recurrent SCs use.”

Haider et al. · From the abstract

Names Vitamin K1 and Warfarin together in an interaction, co-administration, or pharmacokinetic context.

Limitations

What this evidence cannot tell you.

Search-based evidence indexes have real limits, and it is worth being explicit about them:

How to read this page

A literature summary, not guidance.

NutriStack

Track what you actually take.

NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Vitamin K1, Warfarin, and several hundred other substances.

Log your routine, get reminders at the times you choose, and scan a label to add a product. The checker is a research and organisation tool, not a clinical decision aid.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.